Cancer Vaccines
Studies from F.C. Stark and colleagues reveal new findings on cancer vaccines
Published in Vaccine Weekly, July 8th, 2009
According to recent research from Ottawa, Canada, "Induction of it functional CD8(+) T-cell response is the important criterion for cancer vaccines, and it. is unclear whether acute or chronic live vectors are better suited for cancer antigen delivery. We have evaluated the tumor protective ability of two recombinant vectors, Listeria monocytogenes (LM) and Salmonella typhimurium (ST), both expressing ovalbumin (OVA)."
"Although both vectors induced a similar OVA-specific CD8(+) T-cell response in the long term, LM-OVA induced mainly central-phenotype (T-CM, CD44(high)CD62L(high)), whereas ST-OVA induced mainly effector-phenotype (T-EM, CD44(high)CD62L(low)) cells. Both...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2009-07-08)
More Articles from Vaccine Weekly
- McGill University Health Centre
A new weapon in the war against HIV-AIDS: Combined antiviral and targeted chemotherapy - Behavior
Data on behavior discussed by I.M. Bennett and colleagues - Bird Flu
New bird flu study findings recently were reported by researchers at Food & Drug Administration - Chagas Disease
Studies from University of Texas yield new data on Chagas disease - Chronic Obstructive Pulmonary Disease
Findings from E.R. Lafontaine and co-authors broaden understanding of chronic obstructive pulmonary disease - DNA Vaccines
Research from J.Y. Cheng and co-researchers in the area of DNA vaccines published - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
